Oral Arguments Held In Dispute Over Controlled Release Budesonide Tablet
WASHINGTON, D.C. — An appeal of a Delaware federal judge’s determination that a patented pharmaceutical tablet with a core composed of a “macroscopically homogenous composition” for controlling the release of budesonide...To view the full article, register now.
Already a subscriber? Click here to view full article